Literature DB >> 2650514

Importance of magnesium in congestive heart failure.

S S Gottlieb1.   

Abstract

There are many reasons to expect magnesium deficiency in patients with chronic congestive heart failure. Medical therapy, neurohormonal activation and decreased dietary intake could all contribute to low concentrations of serum and muscle magnesium. Although the ideal serum level of this electrolyte is not known, multiple studies have documented lower magnesium concentrations in patients with heart failure than in normal persons. Magnesium deficiency could theoretically produce hemodynamic deterioration and ventricular arrhythmias. These complications have been observed in animals and in patients without heart failure, and magnesium repletion has reversed the adverse effects of hypomagnesemia in some patients. However, the consequences of chronic depletion of the electrolyte have not been adequately evaluated. Because of the high incidence of sudden death in patients with severe congestive heart failure, well designed investigations to determine the importance of magnesium are needed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2650514     DOI: 10.1016/0002-9149(89)90218-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

2.  Hypomagnesemia and cardiovascular system.

Authors:  G Efstratiadis; M Sarigianni; I Gougourelas
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

3.  Nutrition in Pediatric Cardiomyopathy.

Authors:  Tracie L Miller; Daniela Neri; Jason Extein; Gabriel Somarriba; Nancy Strickman-Stein
Journal:  Prog Pediatr Cardiol       Date:  2007-11

4.  Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study.

Authors:  Chris Adamopoulos; Bertram Pitt; Xuemei Sui; Thomas E Love; Faiez Zannad; Ali Ahmed
Journal:  Int J Cardiol       Date:  2008-07-30       Impact factor: 4.164

5.  Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation.

Authors:  N Cohen; D Almoznino-Sarafian; R Zaidenstein; I Alon; O Gorelik; M Shteinshnaider; S Chachashvily; Z Averbukh; A Golik; Z Chen-Levy; D Modai
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

Review 6.  "Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy.

Authors:  B Pitt
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

7.  Mathematical modeling the neuroregulation of blood pressure using a cognitive top-down approach.

Authors:  Graham Wilfred Ewing
Journal:  N Am J Med Sci       Date:  2010-08

Review 8.  Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.

Authors:  Caterina Urso; Salvatore Brucculeri; Gregorio Caimi
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 9.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

10.  Magnesium for the prevention and treatment of cardiovascular disease.

Authors:  James J DiNicolantonio; Jing Liu; James H O'Keefe
Journal:  Open Heart       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.